Johnson & Johnson Eyes Major Leap in Biotech: Talks Underway to Acquire Protagonist Therapeutics in Billion-Dollar Move
In a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire
Read MoreIn a bold bid to expand its cutting-edge drug pipeline, Johnson & Johnson is reportedly in advanced talks to acquire
Read MoreIn a show of technological vigilance and corporate transparency, Google has transformed a major hacking campaign targeting Oracle systems into
Read MoreElon Musk’s groundbreaking Tesla pay package isn’t just about wealth — it’s about fueling the next frontier of innovation in
Read MoreIn a landmark deal marking a new era under CEO Mike Doustdar, Novo Nordisk acquires Akero Therapeutics for up to
Read MoreBarcelona’s teenage star Lamine Yamal is dazzling fans, and coach Hansi Flick is carefully managing his rise to ensure talent,
Read MoreSora, initially available in the United States and Canada, allows users to create short videos — up to ten seconds
Read MoreAI chip pioneer Cerebras withdraws its U.S. IPO filing after a successful $1.1 billion funding round, highlighting strategic growth and
Read MoreNew Delhi – On October 4, 2025, Prime Minister Narendra Modi paid heartfelt tribute to two legendary freedom fighters from
Read MoreA new cannabis-based drug outperforms opioids, offering safer and faster relief for back pain. A revolutionary cannabis-derived treatment offers effective,
Read MoreTech giant Google has flagged a wave of extortion emails targeting executives worldwide, reinforcing its role as a guardian of
Read More